A potential stem cell treatment for chronic liver failure was successfully evaluated by a startup based at the University of Hyderabad (UoH). The company claims that the treatment, known as Tulsi-28X, is the first in the world to employ a unique
Approval has been received by Lupin Limited from the United States Food and Drug Administration for its Abbreviated New Drug Applications for Liraglutide Injection Single-Patient-Use Prefilled Pens and Glucagon for Injection vials...
Under the Production Linked Incentive (PLI) Scheme aimed at increasing domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs)
The historic India-UK Free Trade Agreement (FTA) signed on Thursday will radically boost bilateral trade, particularly in the pharma and medical devices sector, said industry experts.
.jpeg "Zydus Receives Tentative Approval from USFDA for Ibrutinib Tablets")
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received tentative approval from the United States Food and Drug Administration (USFDA) for Ibrutinib tablets 140 mg, 280 mg, and 420 mg (USRLD
Dr Reddy's Laboratories is poised to launch a lower-cost generic version of Novo Nordisk's obesity drug Wegovy (semaglutide) in 87 markets from next year.
Apollo Hospitals and Siemens Healthineers are poised to redefine the diagnosis and treatment of liver disease. The two have announced a collaboration to innovate advanced clinical liver healthcare through the use of AI-enabled imaging...
In a courtroom defeat for Zydus Lifesciences, the Delhi High Court has stayed the company from marketing its proposed biosimilar of the cancer drug Nivolumab
In a move to gain traction in the consumer healthcare market, Torrent Pharmaceuticals has launched Shelcal Total, a complete nutrition supplement powder for adults. “India is facing a growing nutrition gap driven by lifestyle changes...
Cipla Limited said that it entered into definitive agreements to invest in iCaltech Innovations Private Limited by Optionally Convertible Preference Shares.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")